| pubmed-article:15753905 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15753905 | lifeskim:mentions | umls-concept:C0042153 | lld:lifeskim |
| pubmed-article:15753905 | lifeskim:mentions | umls-concept:C0004096 | lld:lifeskim |
| pubmed-article:15753905 | lifeskim:mentions | umls-concept:C0205476 | lld:lifeskim |
| pubmed-article:15753905 | lifeskim:mentions | umls-concept:C0439849 | lld:lifeskim |
| pubmed-article:15753905 | lifeskim:mentions | umls-concept:C0033920 | lld:lifeskim |
| pubmed-article:15753905 | lifeskim:mentions | umls-concept:C0332282 | lld:lifeskim |
| pubmed-article:15753905 | lifeskim:mentions | umls-concept:C0336791 | lld:lifeskim |
| pubmed-article:15753905 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:15753905 | pubmed:dateCreated | 2005-3-8 | lld:pubmed |
| pubmed-article:15753905 | pubmed:abstractText | Risk stratification is used to identify patients with asthma at increased risk of experiencing morbidity and resource utilization. Validated psychometric tools are infrequently studied sources of data for this purpose. | lld:pubmed |
| pubmed-article:15753905 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15753905 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15753905 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:15753905 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15753905 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15753905 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:15753905 | pubmed:issn | 0091-6749 | lld:pubmed |
| pubmed-article:15753905 | pubmed:author | pubmed-author:VollmerWillia... | lld:pubmed |
| pubmed-article:15753905 | pubmed:author | pubmed-author:ZeigerRobert... | lld:pubmed |
| pubmed-article:15753905 | pubmed:author | pubmed-author:CookE... | lld:pubmed |
| pubmed-article:15753905 | pubmed:author | pubmed-author:MendozaGuille... | lld:pubmed |
| pubmed-article:15753905 | pubmed:author | pubmed-author:LeongAlbinA | lld:pubmed |
| pubmed-article:15753905 | pubmed:author | pubmed-author:SchatzMichael... | lld:pubmed |
| pubmed-article:15753905 | pubmed:author | pubmed-author:ApterAndrea... | lld:pubmed |
| pubmed-article:15753905 | pubmed:author | pubmed-author:JohnsonMichae... | lld:pubmed |
| pubmed-article:15753905 | pubmed:author | pubmed-author:MosenDavidD | lld:pubmed |
| pubmed-article:15753905 | pubmed:author | pubmed-author:StiboltThomas... | lld:pubmed |
| pubmed-article:15753905 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15753905 | pubmed:volume | 115 | lld:pubmed |
| pubmed-article:15753905 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15753905 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15753905 | pubmed:pagination | 564-70 | lld:pubmed |
| pubmed-article:15753905 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15753905 | pubmed:meshHeading | pubmed-meshheading:15753905... | lld:pubmed |
| pubmed-article:15753905 | pubmed:meshHeading | pubmed-meshheading:15753905... | lld:pubmed |
| pubmed-article:15753905 | pubmed:meshHeading | pubmed-meshheading:15753905... | lld:pubmed |
| pubmed-article:15753905 | pubmed:meshHeading | pubmed-meshheading:15753905... | lld:pubmed |
| pubmed-article:15753905 | pubmed:meshHeading | pubmed-meshheading:15753905... | lld:pubmed |
| pubmed-article:15753905 | pubmed:meshHeading | pubmed-meshheading:15753905... | lld:pubmed |
| pubmed-article:15753905 | pubmed:meshHeading | pubmed-meshheading:15753905... | lld:pubmed |
| pubmed-article:15753905 | pubmed:meshHeading | pubmed-meshheading:15753905... | lld:pubmed |
| pubmed-article:15753905 | pubmed:meshHeading | pubmed-meshheading:15753905... | lld:pubmed |
| pubmed-article:15753905 | pubmed:meshHeading | pubmed-meshheading:15753905... | lld:pubmed |
| pubmed-article:15753905 | pubmed:meshHeading | pubmed-meshheading:15753905... | lld:pubmed |
| pubmed-article:15753905 | pubmed:meshHeading | pubmed-meshheading:15753905... | lld:pubmed |
| pubmed-article:15753905 | pubmed:meshHeading | pubmed-meshheading:15753905... | lld:pubmed |
| pubmed-article:15753905 | pubmed:meshHeading | pubmed-meshheading:15753905... | lld:pubmed |
| pubmed-article:15753905 | pubmed:meshHeading | pubmed-meshheading:15753905... | lld:pubmed |
| pubmed-article:15753905 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15753905 | pubmed:articleTitle | Relationship of validated psychometric tools to subsequent medical utilization for asthma. | lld:pubmed |
| pubmed-article:15753905 | pubmed:affiliation | Department of Allergy, Kaiser-Permanente Medical Center, San Diego, Calif 92111, USA. michael.x.schatz@kp.org | lld:pubmed |
| pubmed-article:15753905 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15753905 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15753905 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15753905 | lld:pubmed |
